CIZZLE BIOTECHNOLOGY HOLDINGS PLC
CIZ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNG2VN02
- LEI:
- 213800G3OS3SA2J1Y358
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://cizzlebiotechnology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cizzle Biotechnology Holdings PLC develops diagnostic tools for early detection of lung cancer.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-08 10:40 |
Annual Report
Annual Report for the year ended 31 December 2024
|
English | 332.7 KB | |
| 2025-06-06 12:00 |
Report Publication Announcement
Notice of AGM
|
English | 11.4 KB | |
| 2025-05-28 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.1 KB | |
| 2025-03-25 08:00 |
Board/Management Information
Appointment of Non-Executive Director
|
English | 15.7 KB | |
| 2025-01-02 08:00 |
Board/Management Information
Appointment of Professor Dawn Coverley as CSO
|
English | 17.8 KB | |
| 2024-12-16 08:00 |
M&A Activity
Update on Strategic Partnership in North America
|
English | 23.8 KB | |
| 2024-10-21 08:00 |
M&A Activity
Execution of Agreement for North America
|
English | 25.9 KB | |
| 2024-10-03 14:12 |
Regulatory News Service
Update on Licensing and Partnership Agreement
|
English | 10.6 KB | |
| 2024-09-30 08:00 |
Interim Report
Interim Results
|
English | 208.3 KB | |
| 2024-09-16 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 37.5 KB | |
| 2024-09-09 08:00 |
Regulatory News Service
Collaboration with Moffitt Cancer Center
|
English | 25.0 KB | |
| 2024-07-25 08:00 |
Business and Financial Review
Update on Strategic Partnership in North America
|
English | 15.2 KB | |
| 2024-07-18 08:00 |
M&A Activity
Manufacturing Agreement with BBI Solutions
|
English | 21.1 KB | |
| 2024-07-09 08:00 |
Remuneration Information
Issue of Share Options in Lieu of Consultancy Fees
|
English | 14.0 KB | |
| 2024-06-24 13:42 |
Post-Annual General Meeting Information
Result of AGM
|
English | 24.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO |